Jalali F, Moslemi D, Farjam A. First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors. Reports-of-Radiotherapy-and-Onco [Internet]. 24Jan.2015 [cited 18Dec.2025];2(1):1-. Available from: http://waocp.com/journal/index.php/Reports-of-Radiotherapy-and-Onco/article/view/2335